Articles
“The wide range of potential immune-related adverse events requires multidisciplinary, collaborative management by providers across the clinical spectrum,” according to Michael A. Postow, MD, and colleagues. Read More ›
Dr Andrey Antov values the benefits of working within an interdisciplinary team to advance cancer care and help patients. Read More ›
Dr Andrey Antov sees much potential for navigators when it comes to applying genetic and genomic testing to cancer care. Read More ›
Dr Andrey Antov expands on how the healthcare team can work together to provide the best possible care for their patient. Read More ›
Dr Andrey Antov recognizes how important the role of the navigator is in dealing with genetic and genomic testing, as the navigator often needs to help the patient gain access to the appropriate therapy, work with different stakeholders, monitor data, and more. Read More ›
Dr Andrey Antov believes it's important for patients to participate in clinical trials for a multitude of reasons, as clinical trials can benefit both the patient and the healthcare system as a whole. Read More ›
Dr Andrey Antov provides an overview of the role of Jackson Laboratory in the field of cancer genetic testing and in the education of nurses and navigators who co-manage patients at high risk or with a diagnosis of cancer. Read More ›
Dr Andrey Antov identifies situations in which people may want to consider genetic testing. Read More ›
By Wayne Kuznar
At the 2018 NCCN conference, Sharon H. Giordano, MD, MPH, FASCO, Professor of Medicine, Department of Breast Medical Oncology, M.D. Anderson Cancer Center, Houston, provided an update on the treatment of patients with HER2-positive breast cancer, noting an “explosion of new therapies” in recent years that have had a tremendous impact on survival.
Read More ›
Three cancer centers share their experiences related to the struggle of understanding wide variations in the application of sterile compounding and safe handling of oncology hazardous drugs, and the costs and operating burdens of compliance with and adherence to current pharmacy standards.
Read More ›